Buchfelder Michael, Schlaffer Sven-Martin
Department of Neurosurgery, University Hospital Erlangen, Schwabachanlage 6, 91054, Erlangen, Germany.
Pituitary. 2017 Feb;20(1):76-83. doi: 10.1007/s11102-016-0765-7.
Surgical extraction of as much tumour mass as possible is considered the first step of treatment in acromegaly in many centers. In this article the potential benefits, disadvantages and limitations of operative acromegaly treatment are reviewed.
Pertinent literature was selected to provide a review covering current indications, techniques and results of operations for acromegaly.
The rapid reduction of tumour volume is an asset of surgery. To date, in almost all patients, minimally invasive, transsphenoidal microscopic or endoscopic approaches are employed. Whether a curative approach is feasible or a debulking procedure is planned, can be anticipated on the basis of preoperative magnetic resonance imaging. The radicality of adenoma resection essentially depends on localization, size and invasive character of the tumour. The normalization rates of growth hormone and IGF-1 secretion, respectively, depend on tumour-related factors such as size, extension, the presence or absence of invasion and the magnitude of IGF-1 and growth hormone oversecretion. However, also surgeon-related factors such as experience and patient load of the centers have been shown to strongly affect surgical results and the rate of complications. As compared to most medical treatments, surgery is relatively cheap since the costs occur only once and not repeatedly. There are several new technical gadgets which aid in the surgical procedure: navigation and variants of intraoperative imaging.
For the mentioned reasons, current algorithms of acromegaly management suggest an initial operation, unless the patients are unfit for surgery, refuse an operation or only an unsatisfactory resection is anticipated. A few suggestions are made when a re-operation could be considered.
在许多中心,尽可能多地手术切除肿瘤被认为是肢端肥大症治疗的第一步。本文回顾了手术治疗肢端肥大症的潜在益处、缺点和局限性。
选择相关文献以综述肢端肥大症手术的当前适应证、技术和结果。
肿瘤体积的快速缩小是手术的一个优点。迄今为止,几乎所有患者都采用微创经蝶窦显微镜或内镜手术方法。根据术前磁共振成像可以预测是否可行根治性手术或计划进行减瘤手术。腺瘤切除的彻底性主要取决于肿瘤的定位、大小和侵袭性。生长激素和胰岛素样生长因子-1分泌的正常化率分别取决于肿瘤相关因素,如大小、范围、有无侵袭以及胰岛素样生长因子-1和生长激素分泌过多的程度。然而,外科医生相关因素,如中心的经验和患者数量,也已被证明会强烈影响手术结果和并发症发生率。与大多数药物治疗相比,手术相对便宜,因为费用只发生一次,而非反复发生。有几种新技术设备有助于手术过程:导航和术中成像的变体。
由于上述原因,目前肢端肥大症的治疗方案建议首先进行手术,除非患者不适合手术、拒绝手术或预计只能进行不满意的切除。对于何时可以考虑再次手术提出了一些建议。